https://www.tonevresearch.eu https://www.tonevresearch.eu/search https://www.tonevresearch.eu/search-page https://www.tonevresearch.eu/contributions/aclf https://www.tonevresearch.eu/contributions/aih https://www.tonevresearch.eu/contributions/bad-biliary-acid-diarrhea https://www.tonevresearch.eu/contributions/blepharospasm https://www.tonevresearch.eu/contributions/cirrhosis https://www.tonevresearch.eu/contributions/compassionate-use-programs https://www.tonevresearch.eu/contributions/complience-abpi-code https://www.tonevresearch.eu/contributions/cost-effectiveness https://www.tonevresearch.eu/contributions/hbv https://www.tonevresearch.eu/contributions/hcv https://www.tonevresearch.eu/contributions/hdv https://www.tonevresearch.eu/contributions/hiv-1 https://www.tonevresearch.eu/contributions/launch-experience https://www.tonevresearch.eu/contributions/mash https://www.tonevresearch.eu/contributions/medical-education https://www.tonevresearch.eu/contributions/myasthenia-gravis https://www.tonevresearch.eu/contributions/myofascial-pain https://www.tonevresearch.eu/contributions/non-invasive-technologies-for-liver-inflammation-and-fibrosis-nites https://www.tonevresearch.eu/contributions/pandemic-influenza https://www.tonevresearch.eu/contributions/pbc https://www.tonevresearch.eu/contributions/psc https://www.tonevresearch.eu/contributions/publication-planning https://www.tonevresearch.eu/contributions/real-world-evidence https://www.tonevresearch.eu/contributions/sarscov2 https://www.tonevresearch.eu/contributions/scientific-exchange https://www.tonevresearch.eu/contributions/torticollis https://www.tonevresearch.eu/contributions/treatment-of-multi-drug-resistance-mdr-bacteria https://www.tonevresearch.eu/diseases/a-botulinum-toxin-a-treatment-algorithm https://www.tonevresearch.eu/diseases/a-phase-ii-double-blind https://www.tonevresearch.eu/diseases/aclf-1 https://www.tonevresearch.eu/diseases/aclf-2 https://www.tonevresearch.eu/diseases/aih https://www.tonevresearch.eu/diseases/antiviral-effect-of-evusheld https://www.tonevresearch.eu/diseases/bas https://www.tonevresearch.eu/diseases/best-of-liver-at-aasld https://www.tonevresearch.eu/diseases/bristol-myers-squibb https://www.tonevresearch.eu/diseases/changing-perspectives-in-cholestatic-liver-disease-and-pbc https://www.tonevresearch.eu/diseases/cirrhosis https://www.tonevresearch.eu/diseases/comparative-activity-of-tedizolid-versus-glycopeptide-combination-therapies-for-the-treatment-of-staphylococcus-aureus-infections https://www.tonevresearch.eu/diseases/creating-an-rwe-enabled-world https://www.tonevresearch.eu/diseases/diagnostic-options-for-nafld-nash https://www.tonevresearch.eu/diseases/efficacy-and-safety-of-a-single-botulinum-type-a-toxin-complex-treatment https://www.tonevresearch.eu/diseases/emergency-use-instructions-eui https://www.tonevresearch.eu/diseases/functional-liver-assessment-limax-test https://www.tonevresearch.eu/diseases/galectin-3-therapeutic-targeting-in-liver-disease https://www.tonevresearch.eu/diseases/hbv-1 https://www.tonevresearch.eu/diseases/hbv-2 https://www.tonevresearch.eu/diseases/hcv-1 https://www.tonevresearch.eu/diseases/hcv-2 https://www.tonevresearch.eu/diseases/hdv https://www.tonevresearch.eu/diseases/hepatic-impairment-study-design https://www.tonevresearch.eu/diseases/improved-outcome-using-the-limax-test-in-liver-surgery https://www.tonevresearch.eu/diseases/innovation-in-liver-function-diagnostics https://www.tonevresearch.eu/diseases/ipsen-publications-at-aasld-2024 https://www.tonevresearch.eu/diseases/limax-test---analyzing-liver-function-capacity https://www.tonevresearch.eu/diseases/long-term-supportive-cyclical-re-treatment-in-hbeag-negative-ifn-responders https://www.tonevresearch.eu/diseases/madrigal-mgl-3196-nash-phase-iii-study https://www.tonevresearch.eu/diseases/mash-1 https://www.tonevresearch.eu/diseases/mash-2 https://www.tonevresearch.eu/diseases/mash-3 https://www.tonevresearch.eu/diseases/mash-4 https://www.tonevresearch.eu/diseases/mri-diagnostics-2 https://www.tonevresearch.eu/diseases/multi-parametric-mri-as-a-composite-biomarker-for-high-risk-nash https://www.tonevresearch.eu/diseases/multiparametric-magnetic-resonance-imaging https://www.tonevresearch.eu/diseases/multiparametric-mri-as-a-noninvasive-monitoring-tool-for-children-with-autoimmune-hepatitis https://www.tonevresearch.eu/diseases/novel-targets-for-future-management https://www.tonevresearch.eu/diseases/painting-the-new-treatment-landscape-novel-and-emerging-therapies https://www.tonevresearch.eu/diseases/pbc https://www.tonevresearch.eu/diseases/perspectum-aih-guideline https://www.tonevresearch.eu/diseases/pharmacological-management-of-viruses https://www.tonevresearch.eu/diseases/phase-ii-study-of-obeticholic-acid https://www.tonevresearch.eu/diseases/psc https://www.tonevresearch.eu/diseases/regulatory-information-on-trials-of-oseltamivir-tamiflu-and-zanamivir-relenza https://www.tonevresearch.eu/diseases/sivextro-launch-stress-test-workshop https://www.tonevresearch.eu/diseases/tedizolid-phosphate-for-the-treatment-of-acute-bacterial-skin-and-skin-structure-infections-in-adults https://www.tonevresearch.eu/diseases/the-effect-of-multi-parametric-magnetic-resonance-imaging-in-standard-of-care-for-nonalcoholic-fatty-liver-disease https://www.tonevresearch.eu/diseases/the-response-of-patients-with-bile-acid-diarrhoea-to-the-farnesoid-x-receptor-agonist-obeticholic-acid https://www.tonevresearch.eu/diseases/tixagevimab-and-cilgavimab-evusheld